Our 56-day clinical study of 3.1 Dixidox de Luxe Intense Shampoo and 3.4.1 Crexepil de Luxe Forte Lotion involved 46 volunteers aged 18–60. Measured findings included a 31.23% reduction in hair-loss count, a 2.61% increase in hair diameter and a 15.91% reduction in the telogen-phase ratio.

Participant evaluations also described improvements in hair volume, shedding during shampooing and overall hair appearance.

Our 12-week study of 3.4.4 Capixyl™ + Placenta Shock de Luxe Lotion involved 20 volunteers aged 21–67 with androgenetic alopecia. The general evaluation recorded 90% for hair strengthening, 85% for improved hair regeneration and reduced inflammation, and 80% for healthier-looking hair.

These are general evaluation findings, not measured percentage increases in hair strength or growth.

Our dermatologically supervised study followed 25 volunteers aged 23–68 with androgenetic alopecia over approximately 12 weeks. The results list 96% for promotion of hair growth, 92% for reduction of hair loss, 83% for increased hair density and 100% for overall hair improvement.

The published summary does not identify these figures as measured percentage changes in hair count or density.

Our 56-day clinical study of 9.4 Aminopyrrole Lotion with Melatonin involved 46 volunteers aged 18–60. Measured results included a 71.36% reduction in hair-loss count, a 2.71% increase in hair diameter and a 15.55% decrease in the telogen-phase ratio (p < 0.05).

Separately, 100% of participants reported less shedding during shampooing, while 96% perceived an increase in hair volume.

Our 56-day EXOGROW BOOSTER clinical study involved 20 volunteers aged 21–67 using 9.1 EXOGROW BOOSTER Shampoo and 9.4.1 EXOGROW BOOSTER Lotion. In the participant questionnaire, 95% noticed visibly less hair shedding, 90% perceived greater hair density and 81% noticed more baby hairs.

These percentages describe participant feedback, not measured percentage changes in shedding or hair density.

Our 28-day study of 1.3 Dixidox de Luxe Peeling involved 22 volunteers aged 18–65, including participants with sensitive and non-sensitive scalps. Under dermatological supervision, the study reported a 79% reduction in scalp keratin buildup, a 67% improvement in epidermal exfoliation and a 32% reduction in scalp sensitivity.

Magnified scalp photographs document changes observed between day 0 and day 28.

Our 28-day study of 1.3 Dixidox de Luxe Peeling and 2.1 Dixidox de Luxe Antidandruff Shampoo involved 22 volunteers aged 18–65. Under dermatological supervision, the evaluation reported an 81% reduction in scalp keratin buildup, a 60% improvement in epidermal exfoliation and a 52% reduction in scalp sensitivity.

Additional feedback included reduced itching, increased hair volume and improved scalp comfort.